You may have come across the term “clinical trial” while exploring treatment options for your condition. But what exactly are clinical trials, and are they something to think about?
Clinical trials are a type of medical research that test investigational treatments, procedures, or ways of using existing medicines. The goal is to determine whether they are safe and whether they work for a particular condition.
For some people, clinical trials may be an option to consider as part of their treatment journey. However, they are often not well understood. You may have questions about what clinical trials are, how they work, and what taking part might involve.
Learning more about clinical trials can help you decide whether this could be relevant to your situation. This blog aims to provide clear, practical information to help you understand the topic and feel more confident if you choose to explore it further.
A clinical trial is a type of research in which investigational treatments – such as a drugs, devices, procedures or other interventions – are tested in people who voluntarily choose to take part. The aim is to understand whether they are safe and whether they work for a specific condition
Taking part in a clinical trial may help some individuals, but it is important to know that it does not guarantee a cure or improvement. Some people may experience benefits, others may not, and side effects are also possible.
Clinical trials play a critical role in advancing medicine. Many medications, therapies, and medical procedures used today were studied in clinical trials.
Through clinical trials, researchers can:
For people with a specific condition, some clinical trials may offer access to investigational therapies that are not yet widely available.
Some people explore clinical trials when there are limited treatment options for their condition or when standard care is no longer working. Others may consider them earlier as part of conversations with their doctor about possible next steps.
Whether a clinical trial may be a good option depends on each individual situation. That is why it is important to explore clinical trial options together with a doctor or healthcare team.
Clinical trials are typically carried out in several stages called phases. Each phase is designed to answer different research questions.
The design of each phase may vary depending on the disease being studied, the existing standard treatment, and ethical considerations. However, the phases are generally defined as follows:
Researchers study an investigational treatment in a small group of participants. The objective is to evaluate its safety, understand how the body responds to the treatment, determine an appropriate dose, and identify possible side effects.
The treatment is tested in a group of people with the condition it is meant to help. Researchers look at whether it works, while continuing to monitor safety and side effects. In this phase, they also gather more information to help define the most appropriate dose.
Phase 3 trials compare the investigational treatment to existing standard treatments or a placebo. A placebo looks like the treatment being tested but does not contain active medicine. These trials involve larger groups of people and help researchers confirm how well the treatment works. They also help better understand its risks before approval, as less common side effects can also be detected.
Phase 4 trials occur after a treatment has been approved for use. Researchers continue to collect information about long-term safety, as rarer side effects can be detected. Phase 4 clinical trials also allow to evaluate how well the treatment works in larger groups of people.
Understanding these phases helps explain how treatments move from early research to routine medical care. For a more detailed explanation of each clinical trial phase, see the blog “Introducing clinical trials: phase 1–4 explained”

Clinical trials are sometimes described as a “last option,” but that is not always accurate. Trials can play different roles at different points in a person’s care journey.
Some people begin exploring clinical trials when standard treatments are no longer effective or when few approved options exist for their condition. Others may consider a trial earlier, especially if:
The role a clinical trial plays depends on factors such as the condition being studied, available treatments, prior therapies, and the purpose of the trial. A clinical trial is not a replacement for medical care, and it is important to discuss options with your healthcare provider when considering participation.
Understanding where trials may fit can help set realistic expectations and guide conversations with your doctor about whether exploring clinical research makes sense for your situation.

Taking part in a clinical trial can look different from one trial to another. All clinical trials follow a detailed plan called a protocol. This plan sets out what researchers are studying, how the treatment is given, and what kinds of visits, tests, or assessments may be involved. Participants are also monitored throughout the trial to help protect their safety.
Not everyone can join every clinical trial. Each trial has specific rules called eligibility criteria that help determine who the trial is meant for. Before anyone takes part, the clinical trial team explains the purpose of the trial, what participation may involve, and the possible risks and benefits through a process called informed consent.
Some clinical trials assign people to different treatment groups by chance. This is called randomization. Depending on the clinical trial design, one group may receive the investigational treatment, while another may receive standard treatment or, in some cases, a placebo. These approaches may be used to help researchers compare results fairly.
When people first hear about placebos and randomization, it can raise concerns or confusion. Below are some common misunderstandings, and what they usually mean in practice.
“If there’s a placebo, I won’t receive any treatment.”
Not necessarily. In many clinical trials, participants continue to receive standard treatment, and the investigational treatment is added on top. A placebo may be used only when it is considered ethically appropriate and when no proven standard treatment exists for comparison. Some trial designs may also allow people in the placebo group to receive the investigational treatment at a later stage.
“All clinical trials use placebos.”
This is a common misconception. Many trials compare a new treatment to the current standard of care rather than a placebo. Whether a placebo is used depends on the condition, available treatments, and ethical guidelines.
“Randomization means doctors don’t consider what’s best for me”
Randomization is used to ensure that treatment groups are as similar as possible, which helps researchers understand whether differences in outcomes are due to the treatment itself. Even in randomized trials, participants are closely monitored, and safety remains a priority throughout the trial.
Before joining a trial, the research team will clearly explain whether a placebo is involved, how treatment groups are assigned, and what care you would receive in each group. You can ask questions and decide whether the design feels right for you.
Clinical trials are conducted under strict safety and ethical guidelines designed to protect participants.
Before a clinical trial can begin, it must be reviewed and approved by ethics committees or institutional review boards (IRBs). These groups evaluate whether the trial is scientifically appropriate and whether participant safety is protected. Throughout the trial, researchers continue to monitor safety and report any potential concerns.

However, clinical trials can still involve uncertainties and risks, such as:
If you would like to learn more about safety in clinical trials, you can read our dedicated blog, “Introducing Clinical Trials: Safety Information to Consider”
If you decide you want to learn more about clinical trials, you may wish to speak with your doctor, consult trusted clinical trial registries, or explore additional support from services such as myTomorrows, which help patients understand clinical trial options and related information.
Clinical trials can feel complex at first, but understanding the basics can make it easier to decide whether they may be worth exploring as part of your treatment journey.
Here are some of the main points to remember:
No. Each clinical trial has specific eligibility criteria that help determine who the trial is designed for. These may relate to factors such as a person’s condition, medical information, previous treatments, age, or overall health.
They are there to help protect patients and make sure the clinical trial is a good fit for the people it is designed to help. If you are interested in a clinical trial, the clinical trial team can explain whether you may qualify.
It depends on the clinical trial. Some clinical trials last a few weeks, while others can continue for months or longer. The timeline may include screening, treatment, follow-up visits, and safety checks after treatment ends. Before you decide to join, the clinical trial team will explain how long participation is expected to last and what visits may be involved.
Yes. Participation in a clinical trial is voluntary, and you can choose to withdraw at any time, for any reason.
If you decide to leave, the clinical trial team may ask to perform a final check-up to ensure your safety.
No. Clinical trials are not only for people who have run out of treatment options. Some people explore clinical trials when standard care is no longer working, but others may consider them earlier depending on the condition, the treatment being studied, and the purpose of the clinical trial. This matters because clinical trials can play different roles in care and research. Whether a specific clinical trial may be relevant depends on the individual situation and the clinical trial itself.
myTomorrows helps people and their doctors to discover, understand, and explore clinical trial options that may be relevant to their situation. Our Patient Navigators serve as a consistent point of contact, answering questions, sharing clear and practical information, and supporting people throughout the process.
It is important to note that myTomorrows does not provide medical advice, run clinical trials, or make enrollment decisions. Eligibility and participation are determined by the clinical trial teams, and additional support such as funding or travel arrangements is not provided.
Our Patient Navigators are here to help you learn more about clinical trials and how they may be relevant to your specific situation.
If you’d like to speak with a Patient Navigator, you can book a (free) call at a time that suits you.
At myTomorrows, we have a team of Patient Navigators, who are multilingual professionals with a medical background, and can support you with information at the different stages of the clinical trial discovery and access process.
Medical Content Writer at myTomorrows
Dr. Andrea Enguita Marruedo holds a master’s in Genetics and Cell Biology from the Autonomous University of Madrid and a PhD in Developmental Biology from the Erasmus Medical Centre in Rotterdam. She began her career in medical writing after completing her doctoral studies and has covered a wide range of therapeutic areas, including neuromuscular and neurodegenerative disorders, cancer, and diabetes.
Andrea specializes in translating complex biomedical topics into clear, accessible content for patients and healthcare professionals. With a strong research background and a passion for science communication, she is committed to delivering accurate, well-referenced content that supports greater awareness and understanding of medical topics among patients, caregivers, and clinicians.
Andrea Enguita 20 May 2026